Cantab Pharmaceuticals Research Ltd., 310 Cambridge Science Park, Cambridge, CB4 0WG, UK.
Cytotechnology. 1999 Jul;30(1-3):203-10. doi: 10.1023/A:1008005200711.
Disabled Infectious Single Cycle (DISC) HSV-2 has been cultured in the complimentary cell line CR2 to provide high titre bulk material suitable for the purification of the virus as a live viral vaccine. CR2 cells are cultured on the microcarrier Cytodex-1 at 5 g l-1 in small scale (1 l) and larger scale (15 l) reactors. The cells are infected at an MOI of 0.01 pfu cell-1 and the culture harvested 60-72 h later. The infected cells are removed from the microcarriers by the addition of a hypotonic saline and the virus released by low-pressure disruption techniques. Virus titres achieved are compared to the standard roller bottle process. The resulting material is the starting point for the purification of the DISC-HSV virus.
已在互补细胞系 CR2 中培养了失活传染性单循环 (DISC) HSV-2,以提供适合作为活病毒疫苗的高滴度大量材料。CR2 细胞在微载体 Cytodex-1 上以 5 g l-1 的浓度在小规模(1 l)和大规模(15 l)反应器中进行培养。细胞以 0.01 pfu cell-1 的 MOI 感染,并在 60-72 小时后收获培养物。通过添加低渗盐水从微载体中去除感染的细胞,并通过低压破坏技术释放病毒。与标准滚瓶工艺相比,测定病毒滴度。所得材料是纯化 DISC-HSV 病毒的起点。